Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

被引：9

作者：

Fervenza, Fernando C. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN 55901 USA

来源：

NEPHRON CLINICAL PRACTICE | 2011年 / 118卷 / 02期

关键词：

Rituximab; High-dose glucocorticosteroids; Cyclophosphamide; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHURG-STRAUSS-SYNDROME; REFRACTORY WEGENERS-GRANULOMATOSIS; B-LYMPHOCYTE DEPLETION; MICROSCOPIC POLYANGIITIS; MAINTENANCE THERAPY; CYCLOPHOSPHAMIDE; RELAPSE; CELLS;

D O I：

10.1159/000321437

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A number of case reports and case series of patients with Wegener's granulomatosis, microscopic polyangiitis and Churg-Strauss syndrome have supported the use of rituximab (RTX) for the treatment of refractory ANCA-associated vasculitis (AAV). Whether B cell depletion with RTX could replace cyclophosphamide as a first-line therapy for patients with severe AAV remains to be proven. Two studies, recently published in the New England Journal of Medicine, have examined the efficacy of RTX in inducing remission in patients with severe AAV. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：C182 / C188

页数：7

共 50 条

[21] ANCA-associated vasculitis [J].

Yates, Max ;

Watts, Richard .

CLINICAL MEDICINE, 2017, 17 (01) :60-64

[22] ANCA-Associated Vasculitis [J].

Hellmich, B. ;

Pflugfelder, J. .

AKTUELLE RHEUMATOLOGIE, 2013, 38 (05) :300-308

[23] ANCA-associated vasculitis [J].

Moosig, Frank ;

Holle, Julia U. .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (19) :1287-1290

[24] ANCA-ASSOCIATED VASCULITIS [J].

Vandergheynst, F. .

ACTA CLINICA BELGICA, 2013, 68 (06) :406-410

[25] Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis [J].

Nagafuchi, Hiroko ;

Atsumi, Tatsuya ;

Hatta, Kazuhiro ;

Muso, Eri ;

Takeno, Mitsuhiro ;

Yamada, Hidehiro ;

Ozaki, Shoichi .

MODERN RHEUMATOLOGY, 2015, 25 (04) :603-608

[26] Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis? [J].

Besada, Emilio ;

Nossent, Johannes C. .

CLINICAL RHEUMATOLOGY, 2013, 32 (11) :1677-1681

[27] How best to manage relapse and remission in ANCA-associated vasculitis [J].

Puechal, Xavier ;

Guillevin, Loic .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (11) :1135-1143

[28] Rituximab for ANCA-associated vasculitis in the setting of severe infection [J].

Gregersen, J. W. ;

Chaudhry, A. ;

Jayne, D. R. W. .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) :207-210

[29] Renal transplantation in ANCA-associated vasculitis [J].

Segelmark, Marten .

PRESSE MEDICALE, 2013, 42 (04) :568-571

[30] Update on the Treatment of ANCA-associated Vasculitis [J].

Holle, Julia U. ;

Moosig, Frank .

AKTUELLE RHEUMATOLOGIE, 2019, 44 (04) :276-283

← 1 2 3 4 5 →